Effects of Dapagliflozin in Asian Patients With Heart Failure and Reduced Ejection Fraction in DAPA-HF.

Docherty, Kieran F; Anand, Inder S; Chiang, Chern-En; Chopra, Vijay K; Desai, Akshay S; Kitakaze, Masafumi; Verma, Subodh; Vinh, Pham N; Inzucchi, Silvio E; Køber, Lars; Kosiborod, Mikhail N; Martinez, Felipe A; Bengtsson, Olof; Ponikowski, Piotr; Sabatine, Marc S; Sjöstrand, Mikaela; Solomon, Scott D; Langkilde, Anna Maria; Jhund, Pardeep S; McMurray, John J V

Effects of Dapagliflozin in Asian Patients With Heart Failure and Reduced Ejection Fraction in DAPA-HF.

Docherty, Kieran F; Anand, Inder S; Chiang, Chern-En; Chopra, Vijay K; Desai, Akshay S; Kitakaze, Masafumi; Verma, Subodh; Vinh, Pham N; Inzucchi, Silvio E; Køber, Lars; Kosiborod, Mikhail N; Martinez, Felipe A; Bengtsson, Olof; Ponikowski, Piotr; Sabatine, Marc S; Sjöstrand, Mikaela; Solomon, Scott D; Langkilde, Anna Maria; Jhund, Pardeep S; McMurray, John J V.

Afiliação

Docherty KF; BHF Cardiovascular Research Centre, University of Glasgow, Glasgow, Scotland, United Kingdom.
Anand IS; Department of Cardiology, University of Minnesota, Minneapolis, USA.
Chiang CE; Division of Cardiology, Department of Medicine, Taipei Veterans General Hospital and National Yang-Ming University, Taipei, Taiwan.
Chopra VK; Department of Cardiology, Medanta, Gurgaon, India.
Desai AS; Division of Cardiovascular Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
Kitakaze M; Cardiovascular Division of Medicine, National Cerebral and Cardiovascular Center, Osaka, Japan.
Verma S; Division of Cardiac Surgery, St. Michael's Hospital, University of Toronto, Ontario, Canada.
Vinh PN; Department of Internal Medicine, Tan Tao University, Tan Duc, Vietnam.
Inzucchi SE; Section of Endocrinology, Yale University School of Medicine, New Haven, Connecticut, USA.
Køber L; Department of Cardiology, Rigshospitalet Copenhagen University Hospital, Copenhagen, Denmark.
Kosiborod MN; Department of Cardiology, Saint Luke's Mid America Heart Institute, University of Missouri-Kansas City, Kansas City, Missouri, USA.
Martinez FA; National University of Córdoba, Córdoba, Argentina.
Bengtsson O; AstraZeneca, Gothenburg, Sweden.
Ponikowski P; Department of Heart Diseases, Wroclaw Medical University, Wroclaw, Poland.
Sabatine MS; TIMI Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
Sjöstrand M; AstraZeneca, Gothenburg, Sweden.
Solomon SD; Division of Cardiovascular Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
Langkilde AM; AstraZeneca, Gothenburg, Sweden.
Jhund PS; BHF Cardiovascular Research Centre, University of Glasgow, Glasgow, Scotland, United Kingdom.
McMurray JJV; BHF Cardiovascular Research Centre, University of Glasgow, Glasgow, Scotland, United Kingdom.

JACC Asia ; 2(2): 139-153, 2022 Apr.

Article em En | MEDLINE | ID: mdl-36339117

Palavras-chave

ACE, angiotensin-converting enzyme; ARB, angiotensin receptor blocker; Asia; BMI, body mass index; HF, heart failure; HFrEF, heart failure with reduced ejection fraction; KCCQ-TSS, Kansas City Cardiomyopathy Questionnaire total symptom score; LVEF, left ventricular ejection fraction; NT-proBNP, N-terminal proB-type natriuretic peptide; NYHA, New York Heart Association; SBP, systolic blood pressure; SGLT2 inhibitor; SGLT2, sodium-glucose cotransporter 2; eGFR, estimated glomerular filtration rate; ejection fraction; heart failure

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Revista: JACC Asia Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google